https://coincentral.com/roche-holding-ag-rhhby-stock-surge-as-750m-pathai-acquisition-boosts-ai-cancer-diagnostics/
Roche Holding AG (RHHBY) Stock: Surge as $750M PathAI Acquisition Boosts AI Cancer Diagnostics
May 7, 2026 - Roche stock rises as the company agrees to buy PathAI for $750M, expanding AI-powered cancer diagnostics and digital pathology tools.
holding agrochestock
https://www.pathai.com/news/pathai-expands-aisight-clinical-trials-platform-with-launch-of-aim-hi-uc-and-ibdexploretm-for-standardized-histopathology-endpoints
PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExploreTM for...
Mar 2, 2026 - PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExploreTM for Standardized Histopathology Endpoints
clinical trialspathaiexpandsplatformlaunch
https://www.medtechdive.com/news/labcorp-expands-pathai-pact-to-roll-out-digital-pathology-platform-in-us/813043/
Labcorp expands PathAI pact to roll out digital pathology platform in US | MedTech Dive
Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.
out digitalmedtech divelabcorpexpandspathai
https://www.pathai.com/
PathAI | Pathology Transformed
At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clinicians.
pathaipathologytransformed